Company / SG&A Expense
MUSTANG BIO, INC. SG&A Expense History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$6.8M
FY2019
5-year range
$254.0K / $11.4M
FY2016-FY2019
Trend
-40.8%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $254,000 to $7M over the past 2 years.
Based on SEC 10-K filings.
$7M in FY2019 with a 3-year CAGR of +198.5%.
Increased from $254,000 to $7M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +198.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +198.5%, indicating consistent growth.
- In FY2019, sg&a expense decreased 40.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.37 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $6.8M | -40.8% |
| FY2018 | $11.4M | +4391.7% |
| FY2017 | $254.0K | +0.0% |
| FY2016 | $254.0K | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026